NSE - Delayed Quote INR
Metropolis Healthcare Limited (METROPOLIS.NS)
1,712.50
+47.50
+(2.85%)
At close: 3:30:00 PM GMT+5:30
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
13,312,028
13,312,028
12,077,088
11,482,102
12,283,213
Cost of Revenue
2,788,849
2,788,849
2,561,457
2,636,899
2,872,992
Gross Profit
10,523,179
10,523,179
9,515,631
8,845,203
9,410,221
Operating Expense
8,580,035
8,580,035
7,634,554
6,757,000
6,522,067
Operating Income
1,943,144
1,943,144
1,881,077
2,088,203
2,888,154
Net Non Operating Interest Income Expense
-185,747
-185,747
-225,358
-261,427
-138,768
Pretax Income
1,908,529
1,908,529
1,746,889
1,875,034
2,933,511
Tax Provision
453,390
453,390
462,333
441,094
786,650
Net Income Common Stockholders
1,449,683
1,449,683
1,278,162
1,428,826
2,141,821
Diluted NI Available to Com Stockholders
1,449,683
1,449,683
1,278,162
1,428,826
2,141,821
Basic EPS
29.70
28.29
24.95
27.91
41.87
Diluted EPS
29.57
28.15
24.87
27.81
41.66
Basic Average Shares
51,250.54
51,243.66
51,228.94
51,196.40
51,156.13
Diluted Average Shares
51,479.15
51,498.51
51,393.73
51,370.02
51,414.15
Rent Expense Supplemental
--
--
1,052,594
940,999
1,056,703
Total Expenses
11,368,884
11,368,884
10,196,011
9,393,899
9,395,059
Net Income from Continuing & Discontinued Operation
1,449,683
1,449,683
1,278,162
1,428,826
2,141,821
Normalized Income
1,449,683
1,449,683
1,278,162
1,425,102.41
2,025,947.39
Interest Income
--
--
32,625
57,078
111,477
Interest Expense
185,747
185,747
225,358
268,015
197,420
Net Interest Income
-185,747
-185,747
-225,358
-261,427
-138,768
EBIT
2,094,276
2,094,276
1,972,247
2,143,049
3,130,931
EBITDA
3,181,087
3,181,087
2,916,925
3,035,205
3,763,159
Reconciled Cost of Revenue
2,788,849
2,788,849
2,561,457
2,636,899
2,872,992
Reconciled Depreciation
1,086,811
1,086,811
944,678
892,156
632,228
Net Income from Continuing Operation Net Minority Interest
1,449,683
1,449,683
1,278,162
1,428,826
2,141,821
Total Unusual Items Excluding Goodwill
--
--
11,195
4,869
160,898
Total Unusual Items
--
--
11,195
4,869
162,776
Normalized EBITDA
3,181,087
3,181,087
2,916,925
3,030,336
3,600,383
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
1,145.41
43,146.39
3/31/2022 - 4/15/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade